Clinical Trial Update: Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the tolerability of Rebif injections in relapsing-remitting multiple sclerosis with and without the Rebiject Mini autoinjector. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Rebif (interferon beta-1a)
• Rebiject Mini

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis, Relapsing-remitting | Phase 3 | Status: COMPLETED